Table 1

Comparsion of demographics, procedural characteristics, and TEG parameters between the ischemic events group (IEG) and the control group (CG)

IEG (n=18)CG (n=200)p Value
Men13 (72.2%)170 (85%)0.157
Risk factors
 Hypertension9 (50.0%)139 (69.5%)0.090
 Diabetes7 (38.9%)61 (30.5%)0.462
 Hyperlipidemia6 (33.3%)72 (36.0%)0.821
 Smoking8 (44.4%)79 (39.5%)0.100
 Drinking8 (44.4%)61 (30.5%)0.179
 BMI (kg/m2)25.11±4.0325.10±3.070.988
 Prior cerebral infarction3 (16.7%)42 (21.0%)0.664
Hematological data
 ALT (U/L)23.41±12.7829.91±20.390.198
 AST (U/L)18.82±4.6421.83±9.920.125
 GLU (mmol/L)6.13±2.405.39±1.540.067
 BUN (mmol/L)5.48±1.315.56±1.580.838
 Cr (μmol/L)64.73±14.1169.69±17.320.239
 Uric acid (μmol/L)313.18±82.23340.66±80.800.193
 LDL-C (mmol/L)1.74±0.572.05±0.740.100
 HCY (mmol/L)19.97±12.5317.83±12.660.547
 CRP (mg/L)3.48±4.002.28±2.630.091
 HbA1c (%)7.35±0.076.85±1.150.550
 WBC (×109/L)7.27±2.356.91±1.770.435
 RBC (×1012/L)4.45±0.524.64±0.520.142
 PLT (×1012/L)206.82±45.44194.10±50.390.316
 ESR (mm/h)11.42±0.848.80±7.780.225
 PT (s)11.24±9.5411.35±1.040.784
 APTT (s)27.99±4.5928.95±9.870.692
 TIA10 (55.6%)93 (46.5%)
 Ischemic stroke8 (44.4%)96 (49.0%)
 Asymptomatic09 (4.5%)
Stent features
 Number of stent ≥2 (%)3 (16.7%)45 (22.5%)0.769
 Intracranial stent (%)6 (33.3%)49 (24.5%)0.409
TEG parameters
  • AA%, arachidonic acid inhibition rate; ADP%, ADP inhibition rate, ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase ; BMI, body mass index; BUN, blood urea nitrogen; Cr, creatinine; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; GLU, glucose; HbA1c, glycosylated hemoglobin; HCY, homocysteine; INR, International normalized ratio; LDL-C, low-density lipoprotein cholesterol; MA, maximum amplitude; MAADP, ADP-induced platelet-fibrin clot strength; PLT, platelet; PT, prothrombin time; RBC, red blood cells; TEG, thrombelastography; TIA, transient ischemic attack; WBC, white blood cells.